Non-Small Cell Lung Cancer | Oncology Today with Dr Neil Love: Management of Metastatic Non-Small Cell Lung Cancer without an Actionable Mutation (Companion Faculty Lecture)

Featuring a slide presentation and related discussion from Dr Edward Garon, including the following topics: • Immune checkpoint inhibitor therapy for treatment-naïve advanced non-small cell lung cancer (NSCLC) without an actionable mutation (0:00) • Duration of immunotherapy in the frontline setting for NSCLC with no targetable mutation (13:43) • New treatment strategies for relapsed or refractory NSCLC with no targetable mutation (16:25) • Management of antibody-drug conjugate-associated toxicity (19:08) • Activity of antibody-drug conjugates alone or in combination with anti-PD-1 antibodies (26:18) CME information and select publications

Om Podcasten

Featuring the video recorded proceedings of events held in conjunction with important scientific symposia, live webcasts and closed meetings featuring the perspectives of renowned clinical investigators, these videos provide an overview of important advances in the management of a number of solid tumors and hematologic cancers.